
July 2 (Reuters) - Briacell Therapeutics Corp BCT.TO:
BRIACELL HIGHLIGHTS ADDITIONAL PHASE 3 CLINICAL SITES INCLUDING LOS ANGELES CANCER NETWORK AND SMILOW CANCER HOSPITAL AT YALE NEW HAVEN
BRIACELL THERAPEUTICS CORP: ANTICIPATES COMPLETING PATIENT ENROLLMENT IN LATE 2025 OR EARLY 2026 AND MAY REPORT TOP LINE DATA AS EARLY AS H1-2026